GlassScriptPhysician profile
Juan Antonio Alarcon
NPI 1609834217
$27,262.31
in general payments reported to CMS, 2019-2025
35 companies · $1,180 in 2025
The $1,180 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,180 · 2020: $13K · 2021: $1,083 · 2022: $1,542 · 2023: $1,297 · 2024: $1,257 · 2025: $1,180.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,634 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,634.23 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $19,913.45 | 2019-2025 | Speedicath, Saffron |
| Pfizer INC. | $946.87 | 2019-2025 | |
| Sn Holdings, LLC | $868.05 | 2022 | |
| Astellas Pharma US INC | $802.19 | 2019-2024 | Xtandi |
| Sumitomo Pharma America, INC. | $645.70 | 2023-2025 | Gemtesa, Orgovyx |
| Myriad Genetic Laboratories, INC. | $588.06 | 2021-2025 | Prolaris, Myrisk |
| Janssen Biotech, INC. | $560.34 | 2019-2025 | Erleada, Akeega |
| Teleflex LLC | $503.78 | 2021-2025 | Urolift, Barrigel, Solesta |
| Bayer Healthcare Pharmaceuticals INC. | $314.30 | 2019-2025 | |
| Dornier Medtech America, INC | $257.63 | 2021 | |
| Neotract INC. | $214.29 | 2019-2020 | |
| Procept Biorobotics Corporation | $205.56 | 2023-2025 | Aquabeam System, Aquabeam Robotic System |
| Convatec INC. | $198.95 | 2022-2024 | |
| Calyxo, INC. | $166.06 | 2025 | Cvac Aspiration System |
| Medtronic USA, INC. | $153.65 | 2019-2020 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Accord Healthcare, INC. | $147.98 | 2022-2025 | |
| Boston Scientific Corporation | $136.44 | 2019-2025 | Overstitch Endoscopic Suturing System |
| Urovant Sciences INC | $120.50 | 2021-2022 | |
| Myovant Sciences INC. | $101.30 | 2021-2022 | |
| Antares Pharma, INC. | $67.53 | 2021-2022 | |
| Axonics, INC. | $45.99 | 2022 | |
| Dendreon Pharmaceuticals LLC | $44.55 | 2019 | |
| Progenics Pharmaceuticals, INC. | $38.50 | 2024-2025 | |
| Amgen INC. | $33.01 | 2019 | |
| Novartis Pharmaceuticals Corporation | $32.30 | 2025 | |
| Abbvie INC. | $27.71 | 2022 | |
| C. R. Bard, INC. & Subsidiaries | $26.59 | 2020 | |
| Urogen Pharma, INC. | $22.75 | 2022 | |
| Merck Sharp & Dohme LLC | $21.95 | 2023 | Welireg, Keytruda, Lynparza |
| Halozyme INC | $18.58 | 2023 | |
| Endo Pharmaceuticals INC. | $15.97 | 2019 | |
| Ferring Pharmaceuticals INC. | $11.27 | 2019 | |
| Rigicon,INC. | $10.51 | 2023 | Rigi10 Malleable Penile Prosthesis |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$340,127.45 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Juan Alarcon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.